Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Bayer plc
Bayer House, Strawberry Hill, Newbury, Berkshire, RG14 1JA
Telephone: +44 (0)1635 563 000
Fax: +44 (0)1635 563 393
WWW: http://www.bayer.co.uk

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 28/10/2011
PIL Primovist 0.25 mmol/ml, solution for injection, prefilled syringe

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 28/10/2011 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to instructions about overdose
  • Change to side-effects
Updated on 23/07/2010 and displayed until 28/10/2011
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Extra statutory information
Updated on 04/08/2009 and displayed until 23/07/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to storage instructions
  • Change to side-effects
  • Extra statutory information
Updated on 09/03/2009 and displayed until 04/08/2009
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to MA holder contact details
Updated on 25/06/2008 and displayed until 09/03/2009
Reasons for adding or updating:
  • Change to MA holder contact details
  • Change to date of revision
  • Change of licence holder
  • Change to Marketing Authorisation Holder
Updated on 22/10/2007 and displayed until 25/06/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 18/09/2007 and displayed until 22/10/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 19/07/2007 and displayed until 18/09/2007
Reasons for adding or updating:
  • Change to name of manufacturer
Updated on 29/09/2006 and displayed until 19/07/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 18/05/2005 and displayed until 29/09/2006
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  gadoxetic acid, disodium